Market Place
Sourcing Support
Spexis Announces Changes to the Executive Committee
01 Nov 2023 //
GLOBENEWSWIRE
Spexis to host business update conference call on October 9, 2023
06 Oct 2023 //
GLOBENEWSWIRE
Spexis announces financial results for the first half of 2023
29 Sep 2023 //
GLOBENEWSWIRE
Spexis announces appointment of Gonçalo Bernardes as Head of Chemical Biology
28 Sep 2023 //
GLOBENEWSWIRE
Spexis announces USD $2.5M capital commitment to support Phase 3 studies
15 Aug 2023 //
GLOBENEWSWIRE
Spexis announces engagement with Maxim Group LLC as M&A
30 Jun 2023 //
GLOBENEWSWIRE
Spexis announces the publication of results for macrocyclic, peptidomimetic antibiotics
07 Jun 2023 //
GLOBENEWSWIRE
Spexis announces closing of capital commitment of USD 4.5 million
18 Apr 2023 //
GLOBENEWSWIRE
Spexis & SGI Plans for Partnership to Fund PIII Development of ColiFin
08 Feb 2023 //
GLOBENEWSWIRE
Spexis reports solid safety and pharmacokinetics results from murepavadin
09 Jan 2023 //
GLOBENEWSWIRE
Spexis announces promising data with balixafortide with various therapies
13 Dec 2022 //
GLOBENEWSWIRE
Spexis announces promising pre-clinical data with balixafortide in combination
13 Dec 2022 //
GLOBENEWSWIRE
Spexis announces positive renal impairment trial results with balixafortide
22 Sep 2022 //
GLOBENEWSWIRE
Spexis provides business update & announces financial results first half of 2022
06 Sep 2022 //
GLOBENEWSWIRE
Spexis announces presentation of half-y 2022 financial results & participation
30 Aug 2022 //
GLOBENEWSWIRE
Spexis provides business update
27 Jul 2022 //
GLOBENEWSWIRE
Spexis announces business update call to be held on July 28th
20 Jul 2022 //
GLOBENEWSWIRE
Spexis` CXCR4 inhibitor balixafortide shows synergistic efficacy with docetaxel
06 Jul 2022 //
GLOBENEWSWIRE
Spexis to Present at H.C. Wainwright Global Investment Conference
19 May 2022 //
GLOBENEWSWIRE
Spexis Publishes Invitation to Annual General Meeting 2022
01 Apr 2022 //
ACCESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.